Latest News
For the media
Inquiries: Contact communications
CardioSignal Inc strengthens expertise in AgeTech and joins AgeTech Collaborative™ from AARP®
To break barriers in the scalability and accessibility of remote cardiac care technology among older adults, CardioSignal has become a portfolio company of AgeTech Collaborative™ from AARP® after completing its prestigious accelerator program.
CardioSignal appoints former Beddit CEO and Apple Health Tech Manager Lasse Leppäkorpi as Operations Executive
Lasse Leppäkorpi, an entrepreneur, investor, and advisor with over 20 years of experience in health technology business development and biomedical engineering, has joined the CardioSignal team to boost the company’s international expansion.
CardioSignal enters US market, with a focus on accelerating accessibility to remote cardiac care
CardioSignal Inc. announces US market entry with its novel technology for remote cardiac care, focusing on improving earlier detection of atrial fibrillation and heart failure with a smartphone.
OMRON Healthcare announces partnership with CardioSignal to innovate early cardiovascular disease detection and remote patient monitoring at scale
As a first result of the collaboration, CardioSignal atrial fibrillation detection becomes available in OMRON connect app Premium Service in selected countries in Europe.
CardioSignal wins Kasvu Open Award
CardioSignal has won the Kasvu Open award for the Growth Company of the Year. Kasvu Open, one of the biggest startup sparring and acceleration programs in Finland, chose the winners among 200 small and mid-sized companies.
CardioSignal and JISEKI Health advance health equity by introducing a new model in cardiac remote patient monitoring in the USA
CardioSignal, Inc. and JISEKI Health announced their upcoming collaboration. The companies plan to virtualize a care path for earlier detection of heart disease, starting from initial patient engagement, identifying at-risk individuals, and initiating remote patient monitoring. The goal is to improve early detection and health outcomes especially in vulnerable populations.
Contact
For press and material inquiries, please contact : lasse.leppakorpi@cardiosignal.com (tel. +358 50 582 6074)